Elevance Health Inc. (0HG8.L)
USD 437.48
(0.07%)
USD 437.48
(0.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 133.96 Billion USD | 3.48% |
| 2022 | 8.45 Billion USD | -1.97% |
| 2021 | 8.94 Billion USD | 27.04% |
| 2020 | 7.71 Billion USD | 4.23% |
| 2019 | 6.73 Billion USD | 18.09% |
| 2018 | 5.83 Billion USD | 27.86% |
| 2017 | 4.98 Billion USD | -12.99% |
| 2016 | 5.41 Billion USD | -1.63% |
| 2015 | 5.35 Billion USD | 6.02% |
| 2014 | 5.09 Billion USD | 13.75% |
| 2013 | 4.68 Billion USD | -0.65% |
| 2012 | 4.4 Billion USD | -2.33% |
| 2011 | 4.48 Billion USD | -9.09% |
| 2010 | 4.83 Billion USD | -41.19% |
| 2009 | 4.94 Billion USD | 137.09% |
| 2008 | 4.96 Billion USD | -40.62% |
| 2007 | 5.95 Billion USD | 6.99% |
| 2006 | 5.36 Billion USD | 26.32% |
| 2005 | 4.13 Billion USD | 169.54% |
| 2004 | 1.79 Billion USD | 18.39% |
| 2003 | 1.21 Billion USD | 50.95% |
| 2002 | 807.6 Million USD | 53.95% |
| 2001 | 524.6 Million USD | -96.97% |
| 2000 | 17.31 Billion USD | 40.19% |
| 1999 | 12.35 Billion USD | 11.55% |
| 1998 | 11.07 Billion USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 1.71 Billion USD | -43.42% |
| 2024 Q2 | 3.02 Billion USD | -5.56% |
| 2024 Q1 | 3.2 Billion USD | 154.29% |
| 2023 Q1 | 2.87 Billion USD | 101.83% |
| 2023 Q2 | 2.7 Billion USD | -5.85% |
| 2023 FY | -4 Million USD | -100.05% |
| 2023 Q3 | 1.91 Billion USD | -29.2% |
| 2023 Q4 | 1.26 Billion USD | -34.13% |
| 2022 Q2 | 2.33 Billion USD | 0.17% |
| 2022 Q1 | 2.32 Billion USD | 66.14% |
| 2022 Q3 | 2.14 Billion USD | -7.9% |
| 2022 Q4 | 1.15 Billion USD | -46.23% |
| 2022 FY | 7.76 Billion USD | -1.97% |
| 2021 Q1 | 2.17 Billion USD | 256.14% |
| 2021 Q2 | 2.35 Billion USD | 8.13% |
| 2021 Q4 | 1.4 Billion USD | -29.86% |
| 2021 Q3 | 1.99 Billion USD | -15.17% |
| 2021 FY | 7.92 Billion USD | 27.04% |
| 2020 Q4 | 611 Million USD | 57.07% |
| 2020 Q3 | 389 Million USD | -87.65% |
| 2020 FY | 6.23 Billion USD | 4.23% |
| 2020 Q1 | 2.08 Billion USD | 90.26% |
| 2020 Q2 | 3.14 Billion USD | 50.74% |
| 2019 Q3 | 1.48 Billion USD | 2.48% |
| 2019 Q1 | 1.94 Billion USD | 258.2% |
| 2019 Q2 | 1.45 Billion USD | -25.3% |
| 2019 Q4 | 1.09 Billion USD | -26.26% |
| 2019 FY | 5.98 Billion USD | 18.09% |
| 2018 Q4 | 543 Million USD | -56.28% |
| 2018 FY | 5.06 Billion USD | 27.86% |
| 2018 Q3 | 1.24 Billion USD | -17.39% |
| 2018 Q2 | 1.5 Billion USD | -15.55% |
| 2018 Q1 | 1.78 Billion USD | 1333.41% |
| 2017 Q2 | 1.2 Billion USD | -20.42% |
| 2017 Q3 | 1.11 Billion USD | -7.2% |
| 2017 Q4 | 124.2 Million USD | -88.9% |
| 2017 FY | 3.96 Billion USD | -12.99% |
| 2017 Q1 | 1.51 Billion USD | 130.03% |
| 2016 Q3 | 1.13 Billion USD | -21.53% |
| 2016 Q1 | 1.31 Billion USD | 250.52% |
| 2016 FY | 4.55 Billion USD | -1.63% |
| 2016 Q4 | 658.6 Million USD | -42.05% |
| 2016 Q2 | 1.44 Billion USD | 10.39% |
| 2015 Q4 | 374.3 Million USD | -66.86% |
| 2015 Q3 | 1.12 Billion USD | -27.5% |
| 2015 Q2 | 1.55 Billion USD | -0.71% |
| 2015 FY | 4.63 Billion USD | 6.02% |
| 2015 Q1 | 1.56 Billion USD | 76.88% |
| 2014 FY | 4.36 Billion USD | 13.75% |
| 2014 Q4 | 887.1 Million USD | -18.41% |
| 2014 Q3 | 1.08 Billion USD | -13.97% |
| 2014 Q2 | 1.26 Billion USD | 11.82% |
| 2014 Q1 | 1.13 Billion USD | 145.78% |
| 2013 Q2 | 1.21 Billion USD | -5.95% |
| 2013 FY | 3.84 Billion USD | -0.65% |
| 2013 Q4 | 459.8 Million USD | -47.92% |
| 2013 Q3 | 882.8 Million USD | -27.07% |
| 2013 Q1 | 1.28 Billion USD | 167.37% |
| 2012 Q2 | 1.04 Billion USD | -19.94% |
| 2012 Q3 | 1.02 Billion USD | -2.18% |
| 2012 Q4 | 481.4 Million USD | -53.07% |
| 2012 FY | 3.86 Billion USD | -2.33% |
| 2012 Q1 | 1.3 Billion USD | 173.9% |
| 2011 Q4 | 478.2 Million USD | -54.25% |
| 2011 Q3 | 1.04 Billion USD | 3.75% |
| 2011 Q2 | 1 Billion USD | -29.41% |
| 2011 Q1 | 1.42 Billion USD | 89.75% |
| 2011 FY | 3.95 Billion USD | -9.09% |
| 2010 Q2 | 1.12 Billion USD | -15.4% |
| 2010 Q3 | 1.13 Billion USD | 0.64% |
| 2010 Q4 | 752.1 Million USD | -33.84% |
| 2010 FY | 4.35 Billion USD | -41.19% |
| 2010 Q1 | 1.33 Billion USD | -69.23% |
| 2009 Q4 | 4.33 Billion USD | 288.44% |
| 2009 Q2 | 1.05 Billion USD | 17.78% |
| 2009 Q1 | 893.6 Million USD | 75.97% |
| 2009 FY | 7.4 Billion USD | 137.09% |
| 2009 Q3 | 1.11 Billion USD | 6.15% |
| 2008 Q4 | 507.8 Million USD | -7.57% |
| 2008 Q2 | 1.18 Billion USD | 34.9% |
| 2008 Q3 | 549.4 Million USD | -53.68% |
| 2008 Q1 | 879.2 Million USD | -33.53% |
| 2008 FY | 3.12 Billion USD | -40.62% |
| 2007 Q4 | 1.32 Billion USD | -3.54% |
| 2007 Q3 | 1.37 Billion USD | 4.11% |
| 2007 Q2 | 1.31 Billion USD | 5.69% |
| 2007 Q1 | 1.24 Billion USD | -2.91% |
| 2007 FY | 5.25 Billion USD | 6.99% |
| 2006 Q4 | 1.28 Billion USD | 2.33% |
| 2006 Q3 | 1.25 Billion USD | 4.26% |
| 2006 Q2 | 1.2 Billion USD | 2.61% |
| 2006 Q1 | 1.17 Billion USD | 12.61% |
| 2006 FY | 4.91 Billion USD | 26.32% |
| 2005 Q2 | 896.6 Million USD | -3.48% |
| 2005 Q3 | 1.02 Billion USD | 14.14% |
| 2005 FY | 3.89 Billion USD | 169.54% |
| 2005 Q4 | 1.04 Billion USD | 1.76% |
| 2005 Q1 | 928.9 Million USD | 196.39% |
| 2004 Q2 | 363.2 Million USD | -7.49% |
| 2004 Q1 | 392.6 Million USD | 19.77% |
| 2004 FY | 1.44 Billion USD | 18.39% |
| 2004 Q4 | 313.4 Million USD | -16.23% |
| 2004 Q3 | 374.1 Million USD | 3.0% |
| 2003 Q3 | 310.2 Million USD | 11.34% |
| 2003 Q2 | 278.6 Million USD | -7.9% |
| 2003 FY | 1.21 Billion USD | 50.95% |
| 2003 Q4 | 327.8 Million USD | 5.67% |
| 2003 Q1 | 302.5 Million USD | 12.29% |
| 2002 Q3 | 229.4 Million USD | 44.01% |
| 2002 FY | 807.6 Million USD | 53.95% |
| 2002 Q2 | 159.3 Million USD | 6.56% |
| 2002 Q1 | 149.5 Million USD | 8.49% |
| 2002 Q4 | 269.4 Million USD | 17.44% |
| 2001 FY | 524.6 Million USD | -96.97% |
| 2001 Q3 | 177.1 Million USD | 0.0% |
| 2001 Q4 | 137.8 Million USD | -22.19% |
| 2000 FY | 17.31 Billion USD | 40.19% |
| 1999 FY | 12.35 Billion USD | 11.55% |
| 1998 FY | 11.07 Billion USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 101759.672% |
| Accuray Incorporated | 504 Thousand USD | -26579265.079% |
| Align Technology, Inc. | 643.33 Million USD | -20722.647% |
| AxoGen, Inc. | -21.46 Million USD | 624272.957% |
| Boston Scientific Corporation | 2.34 Billion USD | -5617.456% |
| CVS Health Corporation | 13.74 Billion USD | -874.751% |
| Cardinal Health, Inc. | 1.24 Billion USD | -10677.152% |
| Centene Corporation | 2.93 Billion USD | -4472.014% |
| DaVita Inc. | 1.6 Billion USD | -8257.957% |
| HCA Healthcare, Inc. | 9.62 Billion USD | -1291.503% |
| Hologic, Inc. | 970.2 Million USD | -13707.462% |
| Humana Inc. | 4.01 Billion USD | -3238.151% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -12110.061% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -18361.963% |
| Masimo Corporation | 136.5 Million USD | -98039.194% |
| McKesson Corporation | 3.9 Billion USD | -3326.963% |
| Patterson Companies, Inc. | 252.92 Million USD | -52864.527% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -10514.897% |
| ResMed Inc. | 1.31 Billion USD | -10049.308% |
| Henry Schein, Inc. | 615 Million USD | -21682.114% |
| Teladoc Health, Inc. | -248.55 Million USD | 53995.95% |
| Universal Health Services, Inc. | 1.17 Billion USD | -11297.155% |
| Veeva Systems Inc. | 429.33 Million USD | -31101.815% |
| Baxter International Inc. | 390 Million USD | -34248.718% |
| Becton, Dickinson and Company | 2.11 Billion USD | -6245.808% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | -7482.069% |
| Danaher Corporation | 5.38 Billion USD | -2389.5% |
| Stryker Corporation | 3.88 Billion USD | -3345.473% |
| Medtronic plc | 5.14 Billion USD | -2504.199% |